Rocket Pharma Files SEC Update
Rocket Pharmaceuticals updates SEC filing, no details disclosed
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
Huntington Ingalls Industries Reports Quarterly Results
Huntington Ingalls Industries reported results for the quarter ended September 30; no figures were provided.
M impact | EQUITY | Oct 29, 2026, 02:53 PM UTC
Bioextrax Raises SEK 10 Million in Rights and Directed Issues
Bioextrax said it raised SEK 10 million before issue costs through rights and directed issues.
M impact | EQUITY | Oct 29, 2026, 02:53 PM UTC
Adidas CEO Keeps FY Revenue Guidance at 9% to 10%
The CEO said Adidas kept its full-year revenue guidance at 9% to 10%, with possible upside.
M impact | EQUITY | Oct 29, 2026, 02:53 PM UTC
Nasdaq Falls More Than 1% After Alphabet Report
The Nasdaq fell more than 1% after Alphabet’s report heightened concerns about AI spending.
M impact | EQUITY | Oct 29, 2026, 02:53 PM UTC
Jordan Telecommunications Q3 net revenue 95.7 million dinars
M impact | EQUITY | Oct 29, 2026, 02:52 PM UTC
SEG Solar Acquires Land for Planned Cell Factory
SEG Solar acquired land for a planned cell factory.
M impact | EQUITY | Oct 29, 2026, 02:52 PM UTC